Quest Diagnostics (DGX): Rep. Julia Letlow (LA05) disclosed a purchase $1K–$15K
Rep. Julia Letlow (LA05) disclosed a purchase of Quest Diagnostics in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 260 days
- Disclosure lag
- Traded
- Apr 28, 2025
- Disclosed
- Jan 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 27, 2025Insider · 2 peopleInsiders: 2 sales (~$233K)
- Mar 4, 2025Insider · 2 peopleInsiders: 2 sales (~$230K)
- Mar 5, 2025InsiderOfficer sold ~$935K of DGX shares in the open market
- Mar 10, 2025CongressDisclosed sale of DGX — reported range $1,001 - $15,000
- Mar 17, 2025InsiderOfficer sold ~$789K of DGX shares in the open market
- Apr 2, 2025Insider · 2 peopleInsiders: 16 sales (~$7.0M)
What came next
- May 12, 2025InsiderOfficer sold ~$154K of DGX shares in the open market
- May 13, 2025InsiderOfficer sold ~$153K of DGX shares in the open market
- Jul 24, 2025FDAFDA device approval: Quest Diagnostics AAVrh74 Antibody ELISA CDx
- Jul 30, 2025Insider · 1 personInsiders: 2 sales (~$1.4M)
- Jul 31, 2025InsiderOfficer sold ~$376K of DGX shares in the open market
- Aug 6, 2025Insider · 1 personInsiders: 2 sales (~$969K)
- Aug 15, 2025InsiderOfficer sold ~$356K of DGX shares in the open market
- Aug 19, 2025InsiderOfficer sold ~$829K of DGX shares in the open market
- Aug 21, 2025InsiderOfficer sold ~$365K of DGX shares in the open market
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Quest Diagnostics
For Quest Diagnostics, OQRO holds 20 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DGX page.
Other recent filings by Rep. Julia Letlow (LA05)
- House Clerk periodic transaction report at Take-Two Interactive (TTWO)Mar 12, 2026
- House Clerk periodic transaction report at Take-Two Interactive (TTWO)Mar 12, 2026
- House Clerk periodic transaction report at Travelers Companies (The) (TRV)Mar 12, 2026
- House Clerk periodic transaction report at United Rentals (URI)Mar 12, 2026
- House Clerk periodic transaction report at Vistra Corp. (VST)Mar 12, 2026
The full history of Rep. Julia Letlow (LA05) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Quest Diagnostics (DGX) stock, and how much?
Rep. Julia Letlow (LA05) disclosed a purchase of Quest Diagnostics in the $1K–$15K range. Reported range, not an exact amount.
When did it happen, and when was it made public?
Traded: Apr 28, 2025. Disclosed: Jan 13, 2026. That is 260 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Quest Diagnostics recently?
For Quest Diagnostics, OQRO holds 20 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the DGX page.
Does this mean DGX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Quest Diagnostics
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
Everything OQRO holds on this company is on its DGX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data